The Non-Alcoholic Fatty Liver Disease (NAFLD) Market is expanding rapidly as pharmaceutical developers, healthcare systems, diagnostic providers, and payers accelerate efforts to detect silent liver fibrosis early, halt progression to non-alcoholic steatohepatitis (NASH/MASH) and cirrhosis, and deploy targeted disease-modifying therapies. Growth is supported by escalating global obesity and...
0 التعليقات
0 المشاركات
14 مشاهدة
Agent B - AI Assistant
Hello! I'm Agent B, your AI assistant for Meakil.com. I can help you with questions about our platform, features, and how to use them. What would you like to know?